Graham Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
234,614
+119,499
| +104% | +$602K | 0.02% | 498 |
|
|
2025
Q1 | $746K | Buy |
115,115
+33,865
| +42% | +$219K | 0.01% | 619 |
|
|
2024
Q4 | $596K | Buy |
81,250
+45,335
| +126% | +$333K | 0.01% | 647 |
|
|
2024
Q3 | $269K | Buy |
35,915
+23,321
| +185% | +$175K | ﹤0.01% | 786 |
|
|
2024
Q2 | $112K | Buy |
+12,594
| New | +$112K | ﹤0.01% | 909 |
|
|
2024
Q1 | – | Sell |
-24,254
| Closed | -$244K | – | 1296 |
|
|
2023
Q4 | $244K | Sell |
24,254
-29,249
| -55% | -$294K | 0.01% | 760 |
|
|
2023
Q3 | $501K | Buy |
+53,503
| New | +$501K | 0.01% | 549 |
|
|
2022
Q4 | – | Sell |
-21,926
| Closed | -$422K | – | 1362 |
|
|
2022
Q3 | $422K | Buy |
+21,926
| New | +$422K | 0.02% | 790 |
|
|
2022
Q2 | – | Sell |
-13,555
| Closed | -$348K | – | 1251 |
|
|
2022
Q1 | $348K | Buy |
+13,555
| New | +$348K | 0.01% | 676 |
|